| Detected | Trial | Change |
|---|---|---|
| 2026-07-25 | NCT04333524 FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role |
date change Primary completion pushed: 2026-06-15 -> 2026-10-15 |
| 2026-07-25 | NCT04333524 FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role |
date change Completion pushed: 2026-06-15 -> 2026-10-15 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05735834 | Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated… | Splenic Marginal Zone Lymphoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT01808599 | Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal… | MALT Lymphoma | Active, Not Recruiting |
| NCT04646395 | Study of Acalabrutinib and Tafasitamab in MZL Patients | Marginal Zone Lymphoma | Active, Not Recruiting |
| NCT04417166 | Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma | Lymphoma, Extranodal NK-T-Cell | Active, Not Recruiting |
| NCT03697512 | MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas | Marginal Zone Lymphoma | Active, Not Recruiting |
| Not specified | |||
| NCT06712459 | Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma | Transformed Splenic Marginal Zone Lymphoma | Recruiting |
| NCT05700149 | Integrated Molecular and Clinical Profiling to Improve Disease Characterization and… | Nodal Marginal Zone Lymphoma | Recruiting |
| NCT01599559 | Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of… | Primary Mediastinal B-cell Lymphoma | Active, Not Recruiting |
| NCT07147751 | Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma… | Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) | Not Yet Recruiting |
| NCT07376330 | Molecular and Cellular Characterization of MALT Lymphoma | MALT Lymphoma | Not Yet Recruiting |
| NCT04333524 | FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role | Marginal Zone Lymphoma | Active, Not Recruiting |